Avirmax CMC Inc., a spin off entity of Avirmax Inc., opened a state-of-the-art clinical good manufacturing practice (GMP), adeno-associated virus vector (AAV) CDMO facility on May 11. Avirmax has expertise in AAV vector design, engineering, process development, GMP manufacturing, analytical testing and characterization that enable clients to obtain full services in AAV product supply from transgene DNA sequences into final AAV final products. The 20,000 square foot facility containing cGMP su...